1. Home
  2. LGL vs RNXT Comparison

LGL vs RNXT Comparison

Compare LGL & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • RNXT
  • Stock Information
  • Founded
  • LGL 1917
  • RNXT 2012
  • Country
  • LGL United States
  • RNXT United States
  • Employees
  • LGL N/A
  • RNXT N/A
  • Industry
  • LGL Industrial Machinery/Components
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGL Technology
  • RNXT Health Care
  • Exchange
  • LGL Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • LGL 31.5M
  • RNXT 31.6M
  • IPO Year
  • LGL N/A
  • RNXT 2021
  • Fundamental
  • Price
  • LGL $6.50
  • RNXT $1.16
  • Analyst Decision
  • LGL
  • RNXT Strong Buy
  • Analyst Count
  • LGL 0
  • RNXT 1
  • Target Price
  • LGL N/A
  • RNXT $9.00
  • AVG Volume (30 Days)
  • LGL 4.4K
  • RNXT 203.6K
  • Earning Date
  • LGL 03-31-2025
  • RNXT 03-31-2025
  • Dividend Yield
  • LGL N/A
  • RNXT N/A
  • EPS Growth
  • LGL 66.76
  • RNXT N/A
  • EPS
  • LGL 0.07
  • RNXT N/A
  • Revenue
  • LGL $4,130,000.00
  • RNXT N/A
  • Revenue This Year
  • LGL N/A
  • RNXT N/A
  • Revenue Next Year
  • LGL N/A
  • RNXT N/A
  • P/E Ratio
  • LGL $98.87
  • RNXT N/A
  • Revenue Growth
  • LGL 26.49
  • RNXT N/A
  • 52 Week Low
  • LGL $4.86
  • RNXT $0.77
  • 52 Week High
  • LGL $7.00
  • RNXT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • LGL 47.37
  • RNXT 38.10
  • Support Level
  • LGL $6.60
  • RNXT $1.32
  • Resistance Level
  • LGL $7.00
  • RNXT $1.40
  • Average True Range (ATR)
  • LGL 0.26
  • RNXT 0.09
  • MACD
  • LGL -0.04
  • RNXT -0.03
  • Stochastic Oscillator
  • LGL 33.33
  • RNXT 17.07

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: